Categories AlphaGraphs, Analysis, LATEST, Retail

What to expect from Levi Strauss earnings in Q2

Leading jeans brand Levi Strauss (NYSE: LEVI) is scheduled to report second quarter 2019 earnings results after the closing bell on Tuesday, July 9. Analysts expect the company to report earnings of 13 cents per share, on revenues of $1.3 billion.

During the last-reported quarter, the San Francisco, California-based firm swung to an adjusted net profit of $151 million, from a loss in the prior-year period. However, this was not because of the operational performance during this year, but due to the accumulation of some one-off charges last year.

Levi Strauss swung to profit in the first quarter of fiscal 2019 from a loss last year

Net revenues grew by 7% to $1.44 billion, half of which was contributed by the Americas.

Look out for any management discussions relating to capital deployment or opening of new stores. During the last quarter, the company had said that it anticipates capital expenditures of about $190 million to $200 million, and nearly 100 new company-operated store openings in fiscal 2019.

LISTEN TO: Levi Strauss & Co Q1 2019 earnings conference call

After becoming a private company in 1985, the denim company had returned to the public market in March this year. The company, which offered its shares at $17 apiece, has seen its shares rise 28% since then.

Analysts remain quite divided about their opinion on the stock. Three of the six analysts covering LEVI have Buy rating, while the rest three recommend Hold. The stock has a 12-month average price target of $24.67, suggesting upside of 13% from the last close.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top